Literature DB >> 30713592

DATA-DRIVEN CLUSTER SELECTION FOR SUBCORTICAL SHAPE AND CORTICAL THICKNESS PREDICTS RECOVERY FROM DEPRESSIVE SYMPTOMS.

Benjamin S C Wade1,2, Jing Sui3, Stephanie Njau1, Amber M Leaver1, Megha Vasvada1, Boris A Gutman2, Paul M Thompson2, Randal Espinoza4, Roger P Woods1, Christopher C Abbott5, Katherine L Narr1, Shantanu H Joshi1.   

Abstract

Patients with major depressive disorder (MDD) who do not achieve full symptomatic recovery after antidepressant treatment have a higher risk of relapse. Compared to pharmacotherapies, electroconvulsive therapy (ECT) more rapidly produces a greater extent of response in severely depressed patients. However, prediction of which candidates are most likely to improve after ECT remains challenging. Using structural MRI data from 42 ECT patients scanned prior to ECT treatment, we developed a random forest classifier based on data-driven shape cluster selection and cortical thickness features to predict remission. Right hemisphere hippocampal shape and right inferior temporal cortical thickness was most predictive of remission, with the predicted probability of recovery decreasing when these regions were thicker prior to treatment. Remission was predicted with an average 73% balanced accuracy. Classification of MRI data may help identify treatment-responsive patients and aid in clinical decision-making. Our results show promise for the development of personalized treatment strategies.

Entities:  

Keywords:  Random Forest; electroconvulsive therapy; major depression; shape analysis; treatment response prediction

Year:  2017        PMID: 30713592      PMCID: PMC6354762          DOI: 10.1109/ISBI.2017.7950570

Source DB:  PubMed          Journal:  Proc IEEE Int Symp Biomed Imaging        ISSN: 1945-7928


  24 in total

1.  Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyond.

Authors:  Martin B Keller
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

2.  A rating scale for depression.

Authors:  M HAMILTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

3.  Feature selection for shape-based classification of biological objects.

Authors:  Paul Yushkevich; Sarang Joshi; Stephen M Pizer; John G Csernansky; Lei E Wang
Journal:  Inf Process Med Imaging       Date:  2003-07

Review 4.  Remission versus response: the new gold standard of antidepressant care.

Authors:  Martin B Keller
Journal:  J Clin Psychiatry       Date:  2004       Impact factor: 4.384

5.  Brain morphometry with multiecho MPRAGE.

Authors:  André J W van der Kouwe; Thomas Benner; David H Salat; Bruce Fischl
Journal:  Neuroimage       Date:  2008-02-01       Impact factor: 6.556

6.  What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression.

Authors:  Bradley N Gaynes; Diane Warden; Madhukar H Trivedi; Stephen R Wisniewski; Maurizio Fava; A John Rush
Journal:  Psychiatr Serv       Date:  2009-11       Impact factor: 3.084

7.  Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) report.

Authors:  Mustafa M Husain; A John Rush; Max Fink; Rebecca Knapp; Georgios Petrides; Teresa Rummans; Melanie M Biggs; Kevin O'Connor; Keith Rasmussen; Marc Litle; Wenle Zhao; Hilary J Bernstein; Glenn Smith; Martina Mueller; Shawn M McClintock; Samuel H Bailine; Charles H Kellner
Journal:  J Clin Psychiatry       Date:  2004-04       Impact factor: 4.384

8.  Limbic-frontal circuitry in major depression: a path modeling metanalysis.

Authors:  D A Seminowicz; H S Mayberg; A R McIntosh; K Goldapple; S Kennedy; Z Segal; S Rafi-Tari
Journal:  Neuroimage       Date:  2004-05       Impact factor: 6.556

9.  Multidimensional classification of hippocampal shape features discriminates Alzheimer's disease and mild cognitive impairment from normal aging.

Authors:  Emilie Gerardin; Gaël Chételat; Marie Chupin; Rémi Cuingnet; Béatrice Desgranges; Ho-Sung Kim; Marc Niethammer; Bruno Dubois; Stéphane Lehéricy; Line Garnero; Francis Eustache; Olivier Colliot
Journal:  Neuroimage       Date:  2009-05-20       Impact factor: 6.556

Review 10.  Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression.

Authors:  Wayne C Drevets; Joseph L Price; Maura L Furey
Journal:  Brain Struct Funct       Date:  2008-08-13       Impact factor: 3.270

View more
  4 in total

1.  Depressive Symptom Dimensions in Treatment-Resistant Major Depression and Their Modulation With Electroconvulsive Therapy.

Authors:  Benjamin S C Wade; Gerhard Hellemann; Randall T Espinoza; Roger P Woods; Shantanu H Joshi; Ronny Redlich; Anders Jørgensen; Christopher C Abbott; Ketil J Oedegaard; Shawn M McClintock; Leif Oltedal; Katherine L Narr
Journal:  J ECT       Date:  2020-06       Impact factor: 3.692

2.  Mapping abnormal subcortical neurodevelopment in a cohort of Thai children with HIV.

Authors:  Benjamin S C Wade; Victor G Valcour; Thanyawee Puthanakit; Arvin Saremi; Boris A Gutman; Talia M Nir; Christa Watson; Linda Aurpibul; Pope Kosalaraksa; Pradthana Ounchanum; Stephen Kerr; Netsiri Dumrongpisutikul; Pannee Visrutaratna; Jiraporn Srinakarin; Monthana Pothisri; Katherine L Narr; Paul M Thompson; Jintanat Ananworanich; Robert H Paul; Neda Jahanshad
Journal:  Neuroimage Clin       Date:  2019-04-02       Impact factor: 4.881

3.  Magnetic resonance imaging for individual prediction of treatment response in major depressive disorder: a systematic review and meta-analysis.

Authors:  Sem E Cohen; Jasper B Zantvoord; Babet N Wezenberg; Claudi L H Bockting; Guido A van Wingen
Journal:  Transl Psychiatry       Date:  2021-03-15       Impact factor: 6.222

4.  Anterior default mode network and posterior insular connectivity is predictive of depressive symptom reduction following serial ketamine infusion.

Authors:  Benjamin S C Wade; Joana Loureiro; Ashish Sahib; Antoni Kubicki; Shantanu H Joshi; Gerhard Hellemann; Randall T Espinoza; Roger P Woods; Eliza Congdon; Katherine L Narr
Journal:  Psychol Med       Date:  2022-05-17       Impact factor: 10.592

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.